Literature DB >> 11369051

Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.

C Luk1, M S Tsao, J Bayani, F Shepherd, J A Squire.   

Abstract

The overall pattern of chromosomal changes detected by spectral karyotype (SKY) analysis of two cell lines of each major histological subtype of NSCLC, namely squamous cell carcinoma (SQCC) and adenocarcinoma (ADC), indicated a greater degree of chromosomal rearrangement, than was present or predicted by either comparative genomic hybridization (CGH) or G-banding analysis alone. To investigate these observations, CGH was used to screen DNA derived from 8 primary tumors and 15 cell lines. The results indicated that the most frequently gained chromosome arms were 5p (70%), 8q (65%), 15q (52%), 20q (48%), 1q (43%), 19q (39%), 3q (35%), and 11q (35%). Chromosomal losses were less frequently observed, and included 18q (39%), 9 (35%), 6q (30%), 13q (21%), 5q12-q32 (17%), and 19p (17%). Amplifications were found on 2p23-p24, 3q24-q27, 5p, 6cen-p21.1, 6q26, 7p21, 7q31, 8q, 11q13-qter, 20q12-q13.2. Comparison between CGH findings of the two major histological subtypes showed that gains at 1q22-q32.2, 15q, 20q, and losses at 6q, 13q, and 18q was common in ADCs, whereas SQCCs exhibited gains/amplifications at 3q. Distal 8q was gained by CGH in 65% of tumors of both subtypes. Low level MYCC amplification was confirmed by direct fluorescence in situ hybridization (FISH) analysis. The pattern of overall chromosomal changes detected using combinations of molecular cytogenetic analytical methods suggests that it will be easier to detect recurrent subtype-dependent aberrations in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369051     DOI: 10.1016/s0165-4608(00)00363-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  34 in total

Review 1.  Genetic changes in squamous cell lung cancer: a review.

Authors:  Rebecca S Heist; Lecia V Sequist; Jeffrey A Engelman
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

2.  Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1.

Authors:  Min Wang; Haris G Vikis; Yian Wang; Dongmei Jia; Daolong Wang; Laura J Bierut; Joan E Bailey-Wilson; Christopher I Amos; Susan M Pinney; Gloria M Petersen; Mariza de Andrade; Ping Yang; Jonathan S Wiest; Pamela R Fain; Ann G Schwartz; Adi Gazdar; John Minna; Colette Gaba; Henry Rothschild; Diptasri Mandal; Elena Kupert; Daniela Seminara; Yan Liu; Avinash Viswanathan; Ramaswamy Govindan; Marshall W Anderson; Ming You
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 3.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

4.  Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization.

Authors:  Maura Santos Romeo; Irina A Sokolova; Larry E Morrison; Chan Zeng; Anna E Barón; Fred R Hirsch; York E Miller; Wilbur A Franklin; Marileila Varella-Garcia
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

Review 5.  Pulmonary adenocarcinoma: a renewed entity in 2011.

Authors:  Humam Kadara; Mohamed Kabbout; Ignacio I Wistuba
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

6.  Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.

Authors:  Nicola Amodio; Marianna Scrima; Lucia Palaia; Ali Naeem Salman; Alfina Quintiero; Renato Franco; Gerardo Botti; Pino Pirozzi; Gaetano Rocco; Nicla De Rosa; Giuseppe Viglietto
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

7.  Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.

Authors:  William W Lockwood; Raj Chari; Bradley P Coe; Kelsie L Thu; Cathie Garnis; Chad A Malloff; Jennifer Campbell; Ariane C Williams; Dorothy Hwang; Chang-Qi Zhu; Timon P H Buys; John Yee; John C English; Calum Macaulay; Ming-Sound Tsao; Adi F Gazdar; John D Minna; Stephen Lam; Wan L Lam
Journal:  PLoS Med       Date:  2010-07-27       Impact factor: 11.069

8.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

Review 9.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

10.  Profiling the expression pattern of GPI transamidase complex subunits in human cancer.

Authors:  Jatin K Nagpal; Santanu Dasgupta; Sana Jadallah; Young K Chae; Edward A Ratovitski; Antoun Toubaji; George J Netto; Toby Eagle; Aviram Nissan; David Sidransky; Barry Trink
Journal:  Mod Pathol       Date:  2008-05-16       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.